Drug manufacturer Teva Canada Ltd. is recalling two lots of its Teva-Pregabalin 150-milligram capsules after routine testing identified that some pills could be contaminated with the drug sertraline.
The two lots affected by the recall are 100070495 (100-capsule bottle) and 100068913 (500-capsule bottle), which were first sold in Canada in September 2025 and expire on July 31, 2027.
“Patients with a hypersensitivity or allergy to sertraline coul…